Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directorate

 The Board of Directors at its meeting held today, i.e. 11th November, 2022, based on recommendation of Nomination and Remuneration Committee, Audit Committee and subject to the approval of shareholders, approved the re-appointment of Mr. Mritunjay Kumar Singh as an Executive Director of the Company for the term of 5 consecutive years w.e.f. 01.01.2023 upto 31.12.2027. Kindly take the same on record.
11-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter Ended September 30, 2022

 In continuation of our letter dated 02nd November, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at its meeting held today, i.e. 11th November, 2022 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2022. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.15 P.M. Kindly take the same on record.
11-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 11/11/2022

 The Board of Directors at its meeting held today i.e. 11.11.2022 has, inter alia: 1. approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30.09.2022. 2. based on recommendation of the NRC, Audit Committee and subject to the approval of shareholders, approved the re-appointment of Mr. Mritunjay Kumar Singh as an Executive Director of the Company for the term of 5 consecutive years w.e.f. 01.01.2023 upto 31.12.2027. Accordingly, we are enclosing herewith Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30.09.2022 alongwith the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.15 P.M. Kindly take the same on record.
11-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted a Pre-Approval inspection at the Company's manufacturing facility located at St. Louis, USA from 31st October, 2022 to 09th November, 2022. At the end of the inspection, the Company has received Form 483 with three (3) observations. There is no data integrity observation. This Pre-Approval Inspection is part of the routine business operations and the Company shall submit to US FDA within the stipulated timeline, a detailed response to close out the said observations. Kindly take the same on record.
10-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Postal Ballot- Details Of The Voting Results Of The Postal Ballot Through Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In continuation of our letter dated 06th October, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolutions as proposed in the Postal Ballot Notice dated 14th September, 2022 has been passed by the Members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website viz. https://www.alkemlabs.com/Postal-Ballot.php The approval is deemed to have been received on the last date of remote e-voting, i.e. 05th November, 2022.
07-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY23 financial results will be held on Friday, 11th November, 2022 at 05.00 pm. Please find attached herewith the conference call details. Kindly take note of the same.
02-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2022. Kindly take note of the same.
02-11-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) regarding Postal Ballot Notice and E-Voting information. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
07-10-2022
Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 In furtherance to our intimation dated 14.09.2022 this is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Company is in the process of conducting Postal Ballot (only by means of remote e-voting) for seeking approval of Members of the Company for businesses as specified in the Postal Ballot Notice dated 14.09. 2022 ('Postal Ballot Notice'). In terms of Regulation 30 of SEBI Listing Regulations, please find enclosed the Postal Ballot Notice. The remote e-voting period commences on Friday, 07.10.2022 at 9.00 am and shall remain open for a period of 30 days i.e. till Saturday, 05.11.2022 at 5.00 pm. CS Mannish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner.
06-10-2022
Bigul

Alkem Laboratories Ltd - 539523 - Postal Ballot- Details Of The Voting Results Of The Postal Ballot Through Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In continuation of our letter dated 29th August, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 05th August, 2022 has been passed by the Members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website viz. https://www.alkemlabs.com/Postal-Ballot.php The approval is deemed to have been received on the last date of remote e-voting, i.e. 28th September, 2022.
29-09-2022
Next Page
Close

Let's Open Free Demat Account